That is markedly less than the 22% prevalence from the MSI subtype in TCGA analysis, a notable difference which may be explained by the actual fact the fact that analysis involved localized partially, non-metastatic cancers; the occurrence of MSI tumors in the localized placing is certainly higher (about 7%; find below), presumably because these cancers possess a good prognosis and low threat of disease recurrence fairly

That is markedly less than the 22% prevalence from the MSI subtype in TCGA analysis, a notable difference which may be explained by the actual fact the fact that analysis involved localized partially, non-metastatic cancers; the occurrence of MSI tumors in the localized placing is certainly higher (about 7%; find Continue Reading